SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001811764-23-000027
Filing Date
2023-06-13
Accepted
2023-06-13 16:45:22
Documents
12
Period of Report
2023-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pnt-20230612.htm   iXBRL 8-K 35530
  Complete submission text file 0001811764-23-000027.txt   172098

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pnt-20230612.xsd EX-101.SCH 1919
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pnt-20230612_lab.xml EX-101.LAB 23876
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pnt-20230612_pre.xml EX-101.PRE 12533
6 EXTRACTED XBRL INSTANCE DOCUMENT pnt-20230612_htm.xml XML 11224
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39373 | Film No.: 231011804
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences